|
C20ORF94 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.31860000088346E-08 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.825920E-04 |
| Normal-vs-Stage2 |
3.377600E-03 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
1.784030E-02 |
| Stage1-vs-Stage2 |
5.443400E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
3.915400E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
7.688200E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.63390000044117E-07 |
| Normal-vs-AfricanAmerican |
7.63399999881287E-08 |
| Normal-vs-Asian |
1.499360E-01 |
| Caucasian-vs-AfricanAmerican |
1.829000E-01 |
| Caucasian-vs-Asian |
8.927200E-01 |
| AfricanAmerican-vs-Asian |
1.652370E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.785600E-04 |
| Normal-vs-Female |
3.97859999999861E-05 |
| Male-vs-Female |
5.126200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.537950E-02 |
| Normal-vs-Extreme_Weight |
3.770700E-04 |
| Normal-vs-Obese |
4.717600E-03 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
4.404400E-01 |
| Normal_Weight-vs-Obese |
9.758100E-02 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
2.483200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.01309999781074E-08 |
| Normal-vs-Age(41-60Yrs) |
5.178700E-03 |
| Normal-vs-Age(61-80Yrs) |
2.34179999999418E-05 |
| Normal-vs-Age(81-100Yrs) |
5.105000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.559590E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.813980E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.582200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.741200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.633000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.363800E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
7.346800E-01 |
| Normal-vs-Grade 3 |
6.223200E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
6.979600E-01 |
| Grade 2-vs-Grade 4 |
7.346800E-01 |
| Grade 3-vs-Grade 4 |
6.223200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.67864999999212E-05 |
| Normal-vs-N1 |
2.735900E-02 |
| N0-vs-N1 |
1.613840E-01 |
|
|
